Rasio cepet: Xtant Medical Holdings, Inc. (XTNT)

This chart illustrating the historical trend of the quick ratio, which currently stands at 1.08, reveals the approach Xtant Medical Holdings (XTNT) takes toward developing comprehensive spinal surgery systems. A stable reputation among physicians confirms the reliability of their biomaterials. However, expanding production entails costs for laboratories and raw materials, which complicates the rapid growth of operating metrics.

This metric is calculated as the ratio of cash and accounts receivable to current liabilities, excluding low-liquidity inventories from the solvency assessment. For Xtant Medical (XTNT), a leader in the spinal bio-implant segment, the level of highly liquid assets relative to short-term liabilities confirms the ability to fund innovative developments and operational activities without the need for an emergency fire sale of specialized medical tissues.